Completed PHASE3 INTERVENTIONAL 2-arm NCT01279135

Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca Cervix (PARCER)

Phase III Randomized Trial of Image Guided Intensity Modulated Radiotherapy (IG-IMRT) and Conventional Radiotherapy for Late Toxicity Reduction After Postoperative Radiotherapy in Ca Cervix.

Sponsor: Tata Memorial Hospital

Conditions Cancer Cervix

Interventions Conventional Radiation Tomotherapy based IGRT

Updated 9 times since 2017 Last updated: Feb 4, 2026 Started: Jan 1, 2011 Primary completion: Dec 30, 2019 Completion: May 5, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Cancer Cervix, this trial is completed. The trial is conducted by Tata Memorial Hospital and has accumulated 9 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE3
Sep 2024 — Feb 2026 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jul 2020 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

May 2020 — Jul 2020 [monthly]

Completed PHASE3

Status: Unknown Status → Completed
Mar 2018 — May 2020 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Feb 2017 — Mar 2018 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tata Memorial Hospital

Data source: Tata Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Navi Mumbai, India